首页 > 市场调查报告书 > 製药

药用辅料市场规模、份额和成长分析（按产品类型、功能、配方、原料来源、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1897659

药用辅料市场规模、份额和成长分析（按产品类型、功能、配方、原料来源、最终用户和地区划分）－2026-2033年产业预测

Pharmaceutical Excipients Market Size, Share, and Growth Analysis, By Product Type (Organic Chemicals, Inorganic Chemicals), By Functionality (Binders, Fillers/Diluents), By Formulation, By Source, By End User, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 175 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球药用辅料市场规模将达到 101.2 亿美元，到 2025 年将达到 108.1 亿美元，到 2033 年将达到 182.9 亿美元，预测期（2026-2033 年）的复合年增长率为 6.8%。

在药物研发的进步和对高效稳定製剂日益增长的需求推动下，全球药用辅料市场正经历显着的变革。辅料作为关键成分，其作用日益凸显，不仅能增强药物疗效和递送效果，还能提高病患的依从性。活性成分的复杂性，尤其是在生物製药和高效药物中，促使人们需要能够促进溶解度、生物利用度和标靶递送的辅料。市场正越来越多地使用功能性辅料和共加工辅料来优化製剂性能，尤其是在缓释缓释性和掩味系统中。奈米技术和3D列印等创新技术为辅料生产商创造了新的机会。此外，监管机构对辅料品质和安全性的日益重视，推动了符合GMP标准的实施，并促进了新型辅料的问世。

全球药用辅料市场按产品类型、功能、剂型、原料来源、最终用户和地区进行细分。依产品类型划分，可分为有机化学品、无机化学品和其他。依功能划分，可分为粘合剂、填充剂/稀释剂、崩坏、包衣剂、润滑剂、防腐剂、香精/甜味剂、着色剂、溶剂和其他。依製剂形式，可分为口服製剂、外用製剂、注射剂、吸入剂、眼药水、滴鼻液及栓剂。依原料来源划分，可分为天然来源及合成来源。按最终用户划分，可分为製药公司、生物製药公司、契约製造组织 (CMO) 和合约研究组织 (CRO)。依地区划分，可分为北美、亚太、欧洲、拉丁美洲以及中东和非洲。

全球药用辅料市场驱动因素

全球药用辅料市场的主要驱动因素之一是对能够提高生物利用度和治疗效果的客製化药物製剂的需求日益增长。随着製药业向个人化医疗转型，对可用于各种给药系统（包括口服、注射和外用製剂）的专用辅料的需求至关重要。此外，生物製药产业的快速发展也推动了市场扩张，该产业需要先进的辅料来稳定复杂的生物製药和生物相似药。对药物製剂研发的日益重视正在推动辅料产品的创新，从而创造出有利于市场扩张的动态环境。

全球药用辅料市场阻碍因素

全球药用辅料市场的主要限制因素之一是严格的法规环境，该环境对药物製剂中辅料的使用和核准有着严格的规定。监管机构对辅料的品质、安全性和有效性制定了严格的指导方针和标准，这会增加研发成本并延长产品核可时间。遵守这些法规需要对研发、测试和文件编制进行大量投资，这给希望进入市场的中小型製造商设置了重大障碍。此外，这些法规的复杂性可能会抑制创新，限制新型辅料的供应，进一步限制市场成长机会。

全球药用辅料市场趋势

全球药用辅料市场正经历着向多功能和共加工辅料的强劲转变，这主要受效率提升和对创新製剂解决方案的需求所驱动。製药公司越来越重视那些能够简化製剂流程的辅料，这些辅料透过整合关键特性（例如增强结合力、崩坏和流动性）来实现这一目标。共加工辅料能够精细混合多种成分，提供卓越的机械强度和可压性，从而提高药片的均匀性和整体产品性能。这一趋势表明，製药企业致力于简化生产流程，在竞争激烈的市场环境中，透过减少生产步骤来开发复杂的剂型。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Glenmark Pharmaceuticals
Ichnos Sciences
Viatris Inc.
Idorsia Ltd.
BASF SE
Evonik Industries AG
Dow Inc.
Ashland Global Holdings Inc.
JRS Pharma
Colorcon, Inc.
Roquette Freres
CP Kelco
Signet Chemical Corporation

结论与建议

简介目录

Product Code: SQMIG35H2396

Global Pharmaceutical Excipients Market size was valued at USD 10.12 Billion in 2024 and is poised to grow from USD 10.81 Billion in 2025 to USD 18.29 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global pharmaceutical excipients market is experiencing significant shifts due to advancements in drug development and the heightened demand for effective, stable formulations. Excipients are increasingly recognized as vital components that not only enhance drug efficacy and delivery but also improve patient compliance. The complexity of active pharmaceutical ingredients, particularly in biologics and potent drugs, drives the need for excipients that boost solubility, bioavailability, and targeted delivery. The market is witnessing greater use of functional and co-processed excipients that optimize formulation performance, especially in sustained-release and taste-masked systems. Innovations such as nanotechnology and 3D printing present new opportunities for excipient manufacturers. Additionally, regulatory focus on excipient quality and safety fosters the adoption of GMP-compliant standards and supports new excipient introductions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Excipients Market Segments Analysis

Global pharmaceutical excipients market is segmented into product type, functionality, formulation, source, end user and region. Based on product type, the market is segmented into organic chemicals, inorganic chemicals and others. Based on functionality, the market is segmented into binders, fillers/diluents, disintegrants, coating agents, lubricants, preservatives, flavours and sweeteners, colouring agents, solvents and others. Based on formulation, the market is segmented into oral formulations, topical formulations, parenteral formulations, inhalation formulations, ophthalmic formulations, nasal formulations and suppositories. Based on source, the market is segmented into natural and synthetic. Based on end user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, contract manufacturing organizations (CMOs) and contract research organizations (CROs). Based on region the market is segmented as, North America, Asia Pacific, Europe, Latin America, Middle East and Africa.

Driver of the Global Pharmaceutical Excipients Market

One of the key market drivers for the global pharmaceutical excipients market is the increasing demand for tailored drug formulations that enhance bioavailability and therapeutic efficacy. As the pharmaceutical industry shifts towards personalized medicine, the need for specialized excipients that can accommodate varying drug delivery systems, including oral, injectable, and topical formulations, becomes crucial. Additionally, the burgeoning biopharmaceutical sector, which often requires advanced excipients to stabilize complex biologics and biosimilars, further fuels market growth. The rising emphasis on research and development in drug formulation also propels innovation in excipient products, fostering a dynamic environment conducive to market expansion.

Restraints in the Global Pharmaceutical Excipients Market

One key market restraint for the global pharmaceutical excipients market is the stringent regulatory environment governing the use and approval of excipients in drug formulations. Regulatory agencies impose strict guidelines and standards for quality, safety, and efficacy, which can lead to increased development costs and extended timeframes for product approvals. Compliance with these regulations demands extensive investment in research and development, testing, and documentation, posing a significant barrier for smaller manufacturers seeking to enter the market. Additionally, the complexity of these regulations can hinder innovation and limit the availability of novel excipients, further constraining market growth opportunities.

Market Trends of the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market is witnessing a robust shift towards the adoption of multifunctional and co-processed excipients, driven by the need for enhanced efficiency and innovative formulation solutions. Pharmaceutical companies increasingly prioritize excipients that streamline the formulation process by integrating essential properties such as binding, disintegration, and improved flowability. Co-processed excipients, which entail the microscopic blending of multiple components, offer superior mechanical strength and compressibility, thereby enhancing tablet uniformity and overall product performance. This trend signifies a commitment to simplification in manufacturing, allowing for the development of complex dosage forms while minimizing production steps in an increasingly competitive landscape.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Pharmaceutical Excipients Market Size by Product Type & CAGR (2026-2033)

Market Overview
Organic Chemicals
Inorganic Chemicals
Others

Global Pharmaceutical Excipients Market Size by Functionality & CAGR (2026-2033)

Market Overview
Binders
Fillers/Diluents
Disintegrants
Coating Agents
Lubricants
Preservatives
Flavors and Sweeteners
Coloring Agents
Solvents
Others

Global Pharmaceutical Excipients Market Size by Formulation & CAGR (2026-2033)

Market Overview
Oral Formulations
Topical Formulations
Parenteral Formulations
Inhalation Formulations
Ophthalmic Formulations
Nasal Formulations
Suppositories

Global Pharmaceutical Excipients Market Size by Source & CAGR (2026-2033)

Market Overview
Natural
and Synthetic

Global Pharmaceutical Excipients Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Contract Research Organizations (CROs)

Global Pharmaceutical Excipients Market Size & CAGR (2026-2033)

North America (Product Type, Functionality, Formulation, Source, End User)
- US
- Canada
Europe (Product Type, Functionality, Formulation, Source, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Functionality, Formulation, Source, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Functionality, Formulation, Source, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Functionality, Formulation, Source, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Glenmark Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ichnos Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viatris Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Idorsia Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BASF SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dow Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ashland Global Holdings Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JRS Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Colorcon, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roquette Freres
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CP Kelco
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Signet Chemical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments